Impact of Protein Content of Ultraprocessed Foods on the Regulation of Energy Balance
- Conditions
- Healthy
- Interventions
- Other: high protein dietOther: moderate protein diet
- Registration Number
- NCT05337007
- Lead Sponsor
- University of Kiel
- Brief Summary
Aim of the study is to investigate the effects of high-protein, ultraprocessed foods on the regulation of energy balance in a metabolic chamber. The primary outcome parameter of the study is the energy balance (ad libitum energy intake and energy expenditure).
- Detailed Description
Each of the two study weeks starts with a 3-day run-in period with controlled diet at home, following 48 hours in a metabolic chamber. On the day the participants leave the metabolic chamber, they keep a food record over the rest of the day at home.
1. week: meals containing 30 % protein (80 % ultraprocessed high-protein foods), physical activity level (PAL) 1.45, 2 intervention days in the metabolic chamber: ad libitum energy intake
2. week: meals containing 13 % protein (80 % ultraprocessed foods with moderate protein content), physical activity level (PAL) 1.45, 2 intervention days in the metabolic chamber: ad libitum energy intake
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 24
- healthy
- BMI 19-29 kg/m2
- low-medium habitual physical activity
- women with regular menstrual cycle (during intervention in follicular phase)
- smoking
- chronic illnesses (e.g. renal dysfunction)
- regular intake of medication
- food allergies / intolerances
- vegans and vegetarians
- regular high physical activity (exercise >1 hour/d)
- current weight loss diet / weight loss of >5 kg in the last 3 months
- pregnant / lactating women
- persons incapable of giving informed legal consent
- restraint eaters (according to the German version of the 'Three-Factor-Eating-Questionnaire', Stunkard und Messick (1985))
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description dietary intervention, high protein diet high protein diet commercially available high protein ultraprocessed food items (30% protein content), cross-over design, all subjects receive all interventions dietary intervention, moderate protein diet moderate protein diet commercially available moderate protein ultraprocessed food items (13% protein content), cross-over design, all subjects receive all interventions
- Primary Outcome Measures
Name Time Method ad libitum energy intake 24 hours ad libitum energy intake (kcal/day) of the foods consumed (breakfast, lunch, dinner, snacks)
energy expenditure 24 hours measured with indirect calorimetry in a metabolic chamber (kcal/day)
- Secondary Outcome Measures
Name Time Method macronutrient oxidation 24 hours measured with indirect calorimetry in a metabolic chamber (respiratory quotient, RQ)
gastric emptying 5 hours after breakfast on first day of each intervention; intervals 15 min measured with 13C-octanoic acid breath test
appetite regulating hormone - GLP-1 5 hours after breakfast on second day of each intervention; intervals 30 min Glucose Like Peptide-1 concentration in plasma (15 hours AUC; pg/mL)
appetite regulating hormone - PYY 5 hours after breakfast on second day of each intervention; intervals 30 min Peptide YY concentration in plasma (15 hours AUC; pg/mL)
appetite control - subjective feelings of hunger 5 hours after breakfast on first day of each intervention; intervals 30 min measured with visual analogue scales (5 hours AUC; mm x 5 hours). The scale consists of a 10 cm vertical line anchored with "not hungry at all" at the left side and with "extremely hungry" at the right side.
glycemia - glucose AUC 24 hours glucose AUC from continuous glucose monitoring data (mg/dL x 24 hours)
eating rate 3 x 30 per 24 hours (during main meals) time to finish the meals (breakfast, lunch, dinner), (kcal/min; g/min)
oral processing behaviour (chewing) 3 x 30 per 24 hours (during main meals) chews per bite, bite size, oral exposure per bite
appetite regulating hormone - ghrelin 5 hours after breakfast on second day of each intervention; intervals 30 min Ghrelin concentration in plasma (15 hours AUC; pg/mL)
Trial Locations
- Locations (1)
Institute of Human Nutrition
🇩🇪Kiel, Germany